SCHEMBL860722

SCHEMBL860722

C(=C/c1ccnnn1)\c1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.63
KMT2A Q03164 3/20 0.63
GRM4 Q14833 6/20 0.49
HDAC6 Q9UBN7 2/20 0.49
KDM4E B2RXH2 5/20 0.47
NPC1 O15118 2/20 0.47
PKM P14618 2/20 0.47
RAB9A P51151 2/20 0.47
LMNA P02545 2/20 0.47
ALDH1A1 P00352 4/20 0.47
HPGD P15428 4/20 0.47
CYP11B1 P15538 1/20 0.44
CYP11B2 P19099 1/20 0.44
GRM5 P41594 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL466310 1.00 MEN1 (0.63) MEN1KMT2AGRM4HDAC6KDM4E
(Z)-1,2-Diphenylethene SCHEMBL3198659 0.78 CYP11B1 (0.54) MEN1KMT2AGRM4HDAC6KDM4E
SCHEMBL11381421 0.78 MEN1 (1.00) MEN1KMT2AGRM4HDAC6KDM4E
(Z)-1,2-Diphenylethene SCHEMBL529988 0.78 CYP11B1 (0.54) MEN1KMT2AGRM4HDAC6KDM4E
SCHEMBL11381426 0.78 MEN1 (1.00) MEN1KMT2AGRM4HDAC6KDM4E
(Z)-1,2-Diphenylethene SCHEMBL7755679 0.78 CYP11B1 (0.54) MEN1KMT2AGRM4HDAC6KDM4E
SCHEMBL6340037 0.78 MEN1 (0.65) MEN1KMT2AGRM4HDAC6KDM4E
SCHEMBL6340035 0.78 MEN1 (0.65) MEN1KMT2AGRM4HDAC6KDM4E
SCHEMBL29472997 0.77 MEN1 (0.64) MEN1KMT2AGRM4HDAC6KDM4E
SCHEMBL4077027 0.77 MAPT (0.57) KDM4ENPC1RAB9ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4400526-A1 POLYMER AND ORGANIC LIGHT-EMITTING DEVICE USING SAME LG Chem, Ltd. (KR) 2024-07-17 EP disclosed
EP-4400501-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG Chem, Ltd. (KR) 2024-07-17 EP disclosed
EP-4401536-A1 ORGANIC LIGHT-EMITTING DEVICE LG Chem, Ltd. (KR) 2024-07-17 EP disclosed
US-12037337-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-07-16 US disclosed
US-20240237518-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2024-07-11 US disclosed
US-20240208991-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD (KR) 2024-06-27 US disclosed
US-20240215441-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2024-06-27 US disclosed
US-12022730-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-06-25 US disclosed
WO-2024128844-A1 ORGANIC LIGHT EMITTING DEVICE 주식회사 엘지화학 2024-06-20 WO disclosed
US-20240206332-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2024-06-20 US disclosed
EP-2434559-A1 ORGANIC ELECTROLUMINESCENT ELEMENT Idemitsu Kosan Co., Ltd. (JP) 2012-03-28 EP disclosed
US-20110175031-A1 COMPOSITE ORGANIC ELECTROLUMINESCENT MATERIAL IDEMITSU KOSAN CO., LTD. 2011-07-21 US disclosed
EP-2330653-A1 COMPOSITE ORGANIC ELECTROLUMINESCENT MATERIAL Idemitsu Kosan Co., Ltd. (JP) 2011-06-08 EP disclosed
WO-2010144423-A1 STYRYL-TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS ABRAXIS BIOSCIENCE, LLC (US) 2010-12-16 WO disclosed
WO-2010144423-A1 STYRYL-TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS ABRAXIS BIOSCIENCE, LLC (US) 2010-12-16 WO disclosed
US-20100301318-A1 ORGANIC ELECTROLUMINESCENT DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2010-12-02 US disclosed
US-20100301319-A1 ORGANIC ELECTROLUMINESCENT DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2010-12-02 US disclosed
EP-0762195-B1 Sensitization of silver halide emulsions with noble metal complexes EASTMAN KODAK CO (US) 1999-12-15 EP disclosed
EP-0762195-A1 Sensitization of silver halide emulsions with noble metal complexes Imation Corp. (US) 1997-03-12 EP disclosed
US-5556742-A PHOSPHINE AND HALOGEN LIGANDS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1996-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240208991-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CCNL2, UBE2L3 MEN1 1189/4885KMT2A 2222/4885GRM4 4020/4885
US-12037337-B2 Compound and organic light emitting device comprising the same CRY1, CRY2, C1S MEN1 860/4885KMT2A 3366/4885GRM4 1194/4885
US-20240215441-A1 ORGANIC LIGHT EMITTING DEVICE CRY2, CRY1, AHR MEN1 1002/4885KMT2A 1843/4885GRM4 3722/4885
US-12022730-B2 Compound and organic light emitting device comprising the same CRY1, ARRB1, CYP1A1 MEN1 418/4885KMT2A 2915/4885GRM4 528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.